FIGURE 3 from Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors
Dennis Juarez(University of California, Irvine)
Cited by 0
Related Papers
Statins enhance efficacy of venetoclax in blood cancers
|Science Translational Medicine|2018|86
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors
|Cancer Research Communications|2023|13